Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.98
+0.19 (2.16%)
At close: Mar 6, 2026, 4:00 PM EST
9.05
+0.07 (0.76%)
After-hours: Mar 6, 2026, 7:59 PM EST

Zevra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
50644827215930551
Market Cap Growth
20.97%64.53%71.60%-48.00%499.98%268.87%
Enterprise Value
368.76437.99247.5489.34193.79116.24
Last Close Price
8.988.346.554.598.7111.20
PE Ratio
16.71-3.66-5.04-5.88-4.13-3.49
Forward PE
19.52----2.95
PS Ratio
5.9918.969.9115.1610.643.82
PB Ratio
3.7911.284.402.112.40-0.77
P/TBV Ratio
3.719.733.752.112.04-0.67
P/FCF Ratio
--6.43-8.04-8.4329.50-25.77
P/OCF Ratio
--6.43-8.11-8.4729.21-26.21
EV/Sales Ratio
4.3718.559.018.546.768.75
EV/EBITDA Ratio
--5.43-5.09-2.1524.27-21.78
EV/EBIT Ratio
--5.03-4.99-2.1025.07-20.72
EV/FCF Ratio
--6.29-7.32-4.7518.75-58.95
Debt / Equity Ratio
0.471.510.700.180.01-1.05
Debt / EBITDA Ratio
-0.67-0.75-0.90-0.340.20-13.18
Debt / FCF Ratio
--0.87-1.29-0.750.15-35.68
Net Debt / Equity Ratio
-1.03-0.23-0.39-0.91-0.87-1.00
Net Debt / EBITDA Ratio
1.460.110.491.65-13.87-12.39
Net Debt / FCF Ratio
-0.130.713.65-10.71-33.54
Asset Turnover
0.380.130.190.080.401.22
Inventory Turnover
9.797.53----
Quick Ratio
8.292.351.157.5826.920.90
Current Ratio
8.622.531.187.7227.201.11
Return on Equity (ROE)
82.24%-207.84%-67.23%-41.08%-28.19%18.12%
Return on Assets (ROA)
-52.11%-41.18%-34.49%-34.88%10.68%-51.80%
Return on Invested Capital (ROIC)
-163.68%-90.57%-96.78%-197.33%85.98%-412.31%
Return on Capital Employed (ROCE)
-48.25%-71.71%-49.13%-36.64%11.68%-128.22%
Earnings Yield
5.94%-27.34%-19.85%-16.99%-24.23%-28.66%
FCF Yield
-4.79%-15.56%-12.44%-11.86%3.39%-3.88%
Buyback Yield / Dilution
--15.03%-1.06%2.77%-50.98%-4.53%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q